OptiNose Inc - OPTN Net Assets per Single Share

Graphic logo of OptiNose, Inc. (OPTN)

OptiNose, Inc. (OPTN) specializes in sinus therapy via the EDS system and the drug XHANCE, scaling its business through the mass production of high-margin delivery devices. The reference book value per share illustrates the net asset trend, where -6.03 captures the current value of the indicator. Positive cash flow is currently driven by sales of specialized sprays, while marketing optimization has already been priced in by the market.

OptiNose Inc (OPTN): Share Book Value from 07/04/2022 to 05/31/2025

optinose.com - analytical breakdowns and key metrics (OPTN)

- price and consensus price forecast:
Stock Quotes Optinose|OPTN - Analyst Forecast Prices
- market capitalization data:
Market Value OptiNose, Inc.|OPTN - Business Value
- book capitalization data:
Net Assets per Single Share OptiNose|OPTN - Net Asset Value|Market Capitalization to Book Value Ratio optinose.com|OPTN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital OptiNose, Inc.|OPTN - Long-Term Debt to Capital|Short-Term Debt to Equity OptiNose|OPTN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio OptiNose, Inc.
Fundamental company valuation:Optinose - OPTN
Manufactured products of OptiNose

The stability of component supplies for OptiNose, Inc. (OPTN) nasal drug delivery systems ensures asset resilience, which is reflected in the trend of the final book value per share. This metric is calculated as the difference between total assets and liabilities divided by the number of shares, demonstrating the actual amount of equity per share and the level of fundamental investor protection.

Competitors of OptiNose, Inc. (OPTN)

Accounting Value per Share Haleon Group HLN|KVUE: Book Price of a Share|Net Assets per Single Share Verona Pharma plc|MENS (jyongbio.com) - Equity per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share ABVC (abvcpharma.com)|CPIX: Net Assets per Single Share|Quantum BioPharma Ltd. - Net Asset Value per Share|Net Assets per Single Share FibroGen Corp|Telomir Pharmaceuticals Corp (TELO) - Share Book Value|RANI - Accounting Value per Share|Synergy CHC (SNYR) - Book Price of a Share|RLYB: Book Value per Share|Net Assets per Share LEXX|Net Assets per Single Share Pulmatrix Corp PULM|Equity per Share PTHL (ftzy.com.cn)|APM: Net Assets per Single Share|lyratherapeutics.com - Net Asset Value per Share|Net Assets per Single Share IBO (Impact BioMedical Inc)|TNFA - Net Assets per Share|Book Value per Share YCBD|Net Asset Value per Share PainReform Corp|CYTO - Accounting Value per Share|Accounting Value of a Share lipella.com|PIRS (Pieris Pharmaceuticals, Inc.) - Book Value per Share|Net Assets per Share PROC (Procaps Group)|PTPI - Net Assets per Single Share|Equity per Share Qilian International Corp QLI|SLRN: Book Value per Share|tffpharma.com (TFFP) - Accounting Value per Share